Trademarkia Logo

Australia

AU$
OXYCYTE
Ceased - Not renewed: Renewal fee not paid

Last updated on 2 Jan 2020

Owner Info

Tenax Therapeutics, Inc.

One Copley Parkway,

Suite 490, UNITED STATES OF AMERICA

Serial Number

1310933 filed on 26 May 2009

Correspondent

Wendy E. Miller, Cooper & Dunham LLP

30 Rockefeller Plaza, 20th Floor,

New York, NY 10112,

UNITED STATES OF AMERICA

OXYCYTE

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of tissue ischemia, burns, wounds, traumatic brain injury, lung disorders, sickle cell disease, and hair Read More

Mark Details


Serial Number

1310933

Registered On

26 May 2009

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

8 Dec 2008

Mark Type

US

Legal History


Show more

Status DateAction Taken
2th Jan 2020Status change to Removed/Ceased - Not Renewed
22nd Jan 2015IP Right Name Amendment Published
19th Jan 2015Amend Name/Address
15th Jan 2015Amendment to Application/Registration
16th Sept 2011Goods and Services Classes
16th Sept 2011Goods and Services description amendment
30th Jun 2011General Correspondence Registration
6th Apr 2010Goods and Services Classes
6th Apr 2010Goods and Services description amendment
6th Apr 2010Goods and Services description amendment